Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumannii–calcoaceticus complex

Abstract Background: Acinetobacter baumannii–calcoaceticus complex (ABC) isolates are often multidrug-resistant, including to carbapenems. Chromogenic media can facilitate the rapid detection of Gram-negative bacteria, often with the addition of supplements to a base chromogenic medium to detect resistance. We examined various combinations of available media to detect imipenem resistance among 107 ABC clinical isolates. Methods: CHROMagar Orientation, CHROMagar KPC, and CHROMagar Acinetobacter, by itself, with Acinetobacter supplement, with KPC supplement, or CHROMagar Acinetobacter with increasing concentrations (1, 2.5, and 5 ml/l) of a new CR102 supplement, were examined. Results: Sensitivity for the detection of isolates was high (> 98%) for all formulations. Specificity was high for CHROMagar Acinetobacter with 2.5 ml/l and 5 ml/l of the CR102 supplement, at 95.3% and 97.7%, respectively, with positive predictive values of 97% and 98.5%. Negative predictive values of these 2 formulations were 100%. Conclusions: CHROMagar Acinetobacter with the addition of the CR102 supplement at 2.5 ml/l and 5ml/l is highly sensitive and specific for the detection of imipenem-resistant ABC, and may be useful for the rapid detection of imipenem-resistant ABC in clinical samples.

[1]  D. Hospenthal,et al.  Carbapenem Susceptibility Testing Errors Using Three Automated Systems, Disk Diffusion, Etest, and Broth Microdilution and Carbapenem Resistance Genes in Isolates of Acinetobacter baumannii-calcoaceticus Complex , 2011, Antimicrobial Agents and Chemotherapy.

[2]  R. Venezia,et al.  Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[3]  A. Sundsfjord,et al.  Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. , 2011, Journal of medical microbiology.

[4]  Yee-Chun Chen,et al.  Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Renault,et al.  Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak. , 2011, The Journal of hospital infection.

[6]  M. Ilkit,et al.  Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. , 2011, Medical mycology.

[7]  S. Valdezate,et al.  Clonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain , 2010, Journal of Clinical Microbiology.

[8]  P. Courvalin,et al.  Efflux-Mediated Antibiotic Resistance in Acinetobacter spp , 2010, Antimicrobial Agents and Chemotherapy.

[9]  N. Gordon,et al.  Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii , 2010, Journal of Clinical Pathology.

[10]  R. Saito,et al.  Evaluation of a chromogenic agar medium for the detection of extended‐spectrum β‐lactamase‐producing Enterobacteriaceae , 2010, Letters in applied microbiology.

[11]  D. Hospenthal,et al.  Prevalence of multidrug-resistant organisms recovered at a military burn center. , 2010, Burns : journal of the International Society for Burn Injuries.

[12]  K. Carroll,et al.  Evaluation of BBL CHROMagar VanRE for Detection of Vancomycin-Resistant Enterococci in Rectal Swab Specimens , 2010, Journal of Clinical Microbiology.

[13]  F. Baquero,et al.  Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium. , 2010, Diagnostic microbiology and infectious disease.

[14]  M. Falagas,et al.  Treatment of Acinetobacter infections , 2010 .

[15]  Hee-Young Yang,et al.  Evaluation of commercial selective agars in screening for methicillin-resistant Staphylococcus aureus. , 2010, Annals of clinical and laboratory science.

[16]  C. Murray,et al.  CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. , 2010, Diagnostic microbiology and infectious disease.

[17]  J. Boyce,et al.  Evaluation of a New Selective Medium, BD BBL CHROMagar MRSA II, for Detection of Methicillin-Resistant Staphylococcus aureus in Stool Specimens , 2010, Journal of Clinical Microbiology.

[18]  K. Chapin,et al.  Evaluation of a New Selective Medium, BD BBL CHROMagar MRSA II, for Detection of Methicillin-Resistant Staphylococcus aureus in Different Specimens , 2010, Journal of Clinical Microbiology.

[19]  P. Nordmann,et al.  Use of ChromID Extended-Spectrum β-Lactamase Medium for Detecting Carbapenemase-Producing Enterobacteriaceae , 2010, Journal of Clinical Microbiology.

[20]  C. Murray,et al.  Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex , 2010, Journal of Clinical Microbiology.

[21]  N. Gordon,et al.  Evaluation of CHROMagar Acinetobacter for Detection of Enteric Carriage of Multidrug-Resistant Acinetobacter baumannii in Samples from Critically Ill Patients , 2009, Journal of Clinical Microbiology.

[22]  Z. Samra,et al.  Evaluation of CHROMagar KPC for Rapid Detection of Carbapenem-Resistant Enterobacteriaceae , 2008, Journal of Clinical Microbiology.

[23]  Lisa L Maragakis,et al.  Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Clinical,et al.  Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .

[25]  J. Patel,et al.  An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. C. Albrecht,et al.  Impact of Acinetobacter infection on the mortality of burn patients. , 2006, Journal of the American College of Surgeons.

[27]  S. Davies,et al.  Evaluation of a new selective medium for methicillin-resistant Staphyloccocus aureus. , 2001, Journal of medical microbiology.

[28]  M. Ferraro Performance standards for antimicrobial susceptibility testing , 2001 .